|
||
|
||
| [Home Page] [Previous Menu] [Search] |
Marketing authorisation for GMO-medicinal
products for veterinary use
(Author: M. Goossens - Last revised:
October 11, 2011
)
The GMO-medicinal products which have been submitted, completed the full evaluation process and which eventually were or not granted marketing authorisation are listed below in alphabetical order. When available, the date of authorisation is given between brackets. To have details on the product and the authorisation procedure click on the corresponding link.
Equilis StrepE (07/05/2004)
Hiprabovis IBR marker live (27/01/2011)
Nobivac Myxo-RHD (07/09/2011)
Nobi-Porvac Aujeszky (18/12/1993 & 18/07/1994)
ProteqFLU (6/03/2003)
ProteqFLU-Te (6/03/2003)Proteq West Nile (5/08/2011)
Purevax FeLV (formerly Eurifel FeLV) (13/04/2000 - withdrawn in 2007 - no renewal requested)
Purevax rabies (18/02/2011)
Purevax RCPFeLV (formerly Eurifel RCP FelV) (08/03/2002)
Raboral V-RG (19/10/1993)
Suvaxyn Aujeszky (07/08/1998)Vaxxitek HVT + IBD (formerly Gallivac HVT IBD) (9/08/2002)
|